Betapoietin - Wikipedia

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)

This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (February 2014) (Learn how and when to remove this message)

The topic of this article may not meet Wikipedia's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Betapoietin" – news · newspapers · books · scholar · JSTOR (February 2014) (Learn how and when to remove this message)

This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources.
Find sources: "Betapoietin" – news · newspapers · books · scholar · JSTOR (February 2014) (Learn how and when to remove this message)

(Learn how and when to remove this message)

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Betapoietin" – news · newspapers · books · scholar · JSTOR (February 2009) (Learn how and when to remove this message)

Betapoietin is the trade name of erythropoietin beta made by CinnaGen and Zahravi, a hormone treatment for anaemia and sometimes used in chemotherapy

Description

Erythropoietin (EPO) is a hormone produced in the kidneys. The existence of this hormone has been known since 1906, when scientists first started isolating it, and since the 1980s, a recombinant version of the hormone known as Epogen or Betapoietin has been available for use in medical treatment. Betapoietin is the recombinant form of human erythropoietin which is produced in rCHO cells. Beatpoietin has the same characteristics of natural human erythropoietin regarding protein sequence. Betapoietin is composed of 165 amino acids with about 30 KDa molecular weight.

Indication

Betapoietin is used for treatment of anemia due to hemodialysis and also for patients under chemotherapy.

Drug form and potency

Betapoietin is available as ready-to-inject liquid vials (syringe) containing 16 micrograms or 2000IU/ml of rhEPO.

Injection

Injection could be intramuscular or subcutaneous.